Doximity Inc DOCS shares are trading lower Wednesday after the company reported fiscal fourth-quarter results and issued weak guidance.
Q4 Earnings: Doximity said fourth-quarter revenue increased 18% year-over-year to $110.97 million, which narrowly beat consensus estimates of $110.09 million, per Benzinga Pro.
The company reported adjusted earnings of 20 cents per share, which beat estimates of 17 cents per share.
Doximity generated operating cash flow of $46.6 million, down 1% year-over-year. Free cash flow was up 2% year-over-year to $45.6 million.
"With the public health emergency officially over, we're proud to emerge with a record number of providers using our physician cloud in Q4 to power their scheduling, fax, e-signature, and telehealth needs," said Jeff Tangney, co-founder and CEO of Doximity.
Outlook: Doximity said it expects first-quarter revenue to be between $106.5 million and $107.5 million versus estimates of $112.09 million. Full-year revenue is expected to be between $500 million and $506 million versus estimates of $507.05 million.
Following the print, Needham analyst Scott Berg reiterated Doximity with a Buy rating and a $45 price target.
DOCS Price Action: Doximity shares were down 9.33% at $30.70 at the time of publication, according to Benzinga Pro.
Photo: courtesy of Doximity.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.